XBIO
Xenetic Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.67
+0.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.80x
- Price / sales
- 3.36x
- Price / cash flow
- -4.73x
Enterprise value
- Enterprise value
- $4.5M
- EV / sales
- 1.37x
- EV / EBITDA
- -1.81x
- EV / EBIT
- -1.69x
- Market cap
- $10.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026